Sources: OpenAI researcher Miles Wang is leaving the company to launch an AI drug discovery startup, and is in talks to raise $200M at a $2B valuation (Marina Temkin/TechCrunch)

OpenAI researcher Miles Wang is reportedly leaving to launch an AI drug discovery startup. Sources indicate he is in talks to raise $200 million at a $2 billion valuation, with Lightspeed potentially leading the round. Wang's new venture aims to develop AI models for drug discovery, possibly focusing on repurposing existing drugs. Several other OpenAI researchers are expected to join him. Wang disputed the funding figures and company description, but did not provide alternative details.